Google Ventures led a $135m Series D funding round in Encoded Therapeutics, a developer of precision gene therapies. Additional investors include SoftBank Vision Fund, Farallon Capital Management, Menlo Ventures, Meritech Capital Partners, ARCH Venture Partners, Matrix Capital Management Company, Illumina Ventures, Boxer Capital, RTW Investments, Nolan Capital, HBM Genomics. "I am incredibly proud of the progress our organization has made over the past year. We have built an outstanding team, further advanced ETX101 towards the clinic, applied our technology to a series of pipeline programs, and expanded our capabilities to become a fully integrated organization. We are grateful to our investors for supporting our vision to transform patients' lives with cell type-selective genetic medicines," Kartik Ramamoorthi, Encoded Co-Founder and CEO.